Medical Marijuana

Medical Marijuana, Inc. is a pioneering investment holding entity focused on the cannabinoid-based health and wellness industry. Established in 2005 and headquartered in San Diego, California, the company specializes in developing, marketing, and distributing hemp oils rich in cannabinoids, including CBD.

Products and Services

• Hemp oils and non-psychoactive cannabidiol products
• Cannabis-infused chewing gum for therapeutic management
• Dietary supplements and skincare solutions under Kannaway and HempMeds brands

Growth Outlook

• Revenue increased to $3.99 million in Q4 2025, up from $2.99 million in Q3 2025
• Gross profit margin improved to 59.8% in Q4 2025 from 80.6% in Q3 2025
• Continued investment in research and development to innovate product offerings

Financial Highlights

• Net income of -$1.26 million in Q4 2025, reflecting ongoing operational challenges
• Cash and cash equivalents reached $749,445 at the end of Q4 2025
• Operating cash flow was -$1.05 million in Q4 2025, indicating cash management needs

Medical Marijuana, Inc. operates in a rapidly evolving market, capitalizing on the growing demand for cannabinoid-based health products. The company has established a diverse product portfolio, including innovative solutions for both human and pet health. Recent financial performance shows a notable increase in revenue, although challenges remain in achieving profitability. The focus on research and development positions the company to adapt and thrive in a competitive landscape. Investors may find the company's commitment to innovation and market expansion appealing as it navigates the complexities of the cannabinoid industry.